NIH-funded research NIH-funded research

FearLess: coping support for people with malignant brain tumors and their caregivers

Official title: Investigating Feasibility and Acceptability of the FearLess Protocol for Patients with Primary Malignant Brain Tumors and Their Caregivers

Funded at Virginia Commonwealth University · NIH-11193808 · Data updated 2026-11-12

This project will try a new FearLess therapy to help people with malignant brain tumors and their caregivers manage fear of the cancer coming back.

More Caregivers research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVirginia Commonwealth University
NIH-funded
Lab location1 site (Richmond, United States)
Project startSeptember 17, 2024
Project endAugust 31, 2027
Funding year2025
Award (this year)$288,940
NIH project number5R34CA286879-02
Project IDNIH-11193808 on NIH RePORTER

Who could benefit from this research

Could help

Adults with primary malignant brain tumors and their unpaid caregivers who report significant fear of cancer recurrence and can attend scheduled therapy sessions are the ideal candidates.

Less likely to help

People with severe cognitive or language impairments that prevent participating in psychotherapy, those who are medically unstable, or those without notable fear of recurrence may not benefit from this intervention.

What this research studies

You and a caregiver would be offered the FearLess program, a short manualized therapy that combines mindfulness and cognitive‑existential techniques to address fear of cancer recurrence. Participants are placed into one of two groups so the team can see whether people can join, stick with the program, and find it acceptable compared with a control approach. The researchers will test different recruitment methods, check which patients and caregivers can participate given neurological challenges, and refine the control condition before a larger trial. The study will collect feedback and measures of fear, daily function, coping, and treatment adherence to guide next steps.

Why it matters

Potential benefit: If successful, FearLess could reduce fear of cancer coming back, improve daily functioning and coping, and support better adherence to medical care for patients and their caregivers.

How similar studies have gone: Mindfulness and cognitive approaches have helped reduce fear of recurrence in other cancer groups, but this tailored FearLess program is new for neuro‑oncology patients and their caregivers.

Where this research is happening

  • Virginia Commonwealth University
    Richmond, United States
    Active

Researchers

  • Principal investigator: Loughan, Ashlee Ruth — Virginia Commonwealth University
  • Study coordinator: Loughan, Ashlee Ruth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.